Skip to main content
MEMPHASYS LIMITED. logo

MEMPHASYS LIMITED. — Investor Relations & Filings

Ticker · MEM ISIN · AU000000MEM5 LEI · 549300RZ3LBXHF3WXL97 ASX Professional, scientific and technical activities
Open in API
Filings indexed 1,223 across all filing types
Latest filing 2007-09-11 Capital/Financing Update
Country AU Australia
Listing ASX MEM

About MEMPHASYS LIMITED.

https://www.memphasys.com/

Memphasys Limited is a biotechnology company specializing in the development of advanced cell separation and reproductive biotechnology solutions. The company's core technology platform utilizes proprietary membranes and electrophoresis to isolate high-quality cells from biological fluids. Its flagship product, the Felix™ system, is an automated device designed for the rapid separation of high-quality sperm from semen samples for use in human assisted reproductive technology (ART) procedures. This technology aims to improve clinical outcomes by selecting sperm with lower DNA fragmentation and higher motility compared to traditional centrifuge-based techniques. Beyond human fertility, the company applies its bio-separation expertise to animal health, including diagnostic tools for stallion fertility. Memphasys focuses on providing innovative solutions that enhance efficiency and success rates in the global reproductive health market.

Recent filings

Filing Released Lang Actions
NuSep raises $2.7m under Share Purchase Offer 2 pages ?Kb
Capital/Financing Update Classification · 95% confidence The document is a press release announcing that NuSep Ltd has raised $2.7 million under a Share Purchase Offer (SPO). It details the use of funds, the closing date of the offer, the upcoming Extraordinary General Meeting (EGM) for share issuance approval, and information about the company's business. There are no financial statements, detailed financial analysis, or regulatory form references. The document is an update on a capital raising event, specifically a share purchase offer, which fits the Capital/Financing Update category. The document length is under 5,000 characters and is a standalone announcement, not a report or filing. Therefore, the appropriate classification is Capital/Financing Update (CAP).
2007-09-11 English
NSP Appendix 3Y Change of Directors Interest Notice 2 pages ?Kb
Director's Dealing Classification · 100% confidence The document is titled 'Change of Director’s Interest Notice' and references ASX listing rule 3.19A.2 and section 205G of the Corporations Act. It details a director's acquisition of shares, including dates, number of shares before and after the change, and transaction type (on-market trade). This matches the definition of a Director's Dealing report, which involves personal share transactions by company directors and executives. The document length is short and focused solely on this transaction, with no financial statements or other report content. Therefore, it is classified as a Director's Dealing (DIRS) filing.
2007-09-02 English
NSP Extension of Share Purchase Offer 2 pages ?Kb
Capital/Financing Update Classification · 95% confidence The document is a letter dated 31 August 2007 from the Chairman to shareholders regarding the extension of a Share Purchase Offer (SPO) closing date. It discusses details about the SPO, share prices, shareholder actions, and a timetable for the offer and related general meeting. There is no financial statement or detailed financial analysis present. The document is an announcement related to capital raising activity (share purchase offer) and changes in shareholding opportunities. It is not a full financial report, earnings release, or regulatory filing. The content fits best under Capital/Financing Update (CAP) as it provides an update on a financing activity (share purchase offer extension). The document length is 4048 characters, which is sufficient for a detailed announcement but not a full report. Therefore, the classification is CAP with high confidence.
2007-08-30 English
NuSep Extension of Share Purchase Offer by 2 weeks 2 pages ?Kb
Capital/Financing Update Classification · 95% confidence The document is a press release announcing the extension of a Share Purchase Offer (SPO) by NuSep Ltd. It details the offer terms, background on the shareholding structure, and the revised timetable for the offer and related shareholder meeting. There is no financial report, earnings data, or detailed financial statements included. The document is focused on capital raising activity and shareholder offer details, which aligns with a Capital/Financing Update. The length is about 4663 characters, which is consistent with a detailed announcement rather than a full report. Therefore, the appropriate classification is Capital/Financing Update (CAP).
2007-08-23 English
Appendix 4E 11 pages ?Kb
Annual Report Classification · 95% confidence The document is titled 'Appendix 4E Full Year Preliminary Results 30 June 2007' and contains detailed financial statements including income statement, balance sheet, cash flow statement, statement of changes in equity, segment reporting, and notes. It covers the full financial year ended 30 June 2007. The document includes comprehensive financial data and analysis, not just an announcement or summary. Appendix 4E is a regulatory form used in Australia for preliminary final reports, which is equivalent to an annual report or full year financial report. Given the detailed financial content and the full year period, this document fits the definition of an Annual Report (10-K equivalent).
2007-08-23 English
NuSep Official Opening and Business Presentations 39 pages ?Kb
Investor Presentation Classification · 95% confidence The document is a press release announcing the opening of NuSep's head office and includes business presentations by the CEO and other experts. It contains detailed business updates, strategic outlook, and product information. The content is primarily a business update and presentation material shared with shareholders and guests at an event. There is no indication of formal financial statements, regulatory filings, or voting results. The document is not a full annual or interim report, nor is it a transcript of a call or an audit report. It fits best as an Investor Presentation (IP) because it provides detailed information on business strategy, market positioning, and product development aimed at investors and stakeholders.
2007-08-23 English

Browse filings by year

20 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.